Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Continuing Care App for Probationers and Parolees

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04574193
Recruitment Status : Not yet recruiting
First Posted : October 5, 2020
Last Update Posted : January 26, 2021
Sponsor:
Collaborator:
Friends Research Institute, Inc.
Information provided by (Responsible Party):
Steven Carswell, COG Analytics

Brief Summary:
This project extends successful Phase I work that developed a Continuing Care mobile application (app) for probationers and parolees with SUDs who are at elevated risk of relapse, re-arrest, and incarceration. This Phase II STTR project will finalize app development and evaluate its efficacy in a randomized controlled trial. The project has high public health significance due to its potential to provide an accessible recovery support tool for individuals on probation or parole that could improve their substance use disorder treatment outcomes.

Condition or disease Intervention/treatment Phase
Substance Use Disorders Device: digital therapeutic for substance use disorders Other: Treatment As Usual Not Applicable

Detailed Description:

Substance use disorders (SUDs) continue to be one of the most serious public health problems in the US. Studies have consistently documented a substantially higher prevalence of SUDs among adults under criminal justice supervision in the community (i.e., probation or parole) as compared to the general population. There is growing recognition that addiction is a chronic health condition, and individuals with SUDs typically cycle through multiple periods of treatment, abstinence, and relapse over several years to achieve and maintain recovery. Studies show that continuing care interventions can provide ongoing support or extend primary treatment gains with respect to reducing substance use, relapse, and criminal activity. Recent diffusion of Internet and smartphone technologies among disadvantaged populations now offers unprecedented opportunities for increasing access to quality continuing care interventions as well as chronic disease self-management tools. Probationers and parolees at high risk for drug abuse relapse and involvement in health compromising behaviors are an important population that stands to benefit from continuing care technologies. However, to date, no such technologies exist that are specifically tailored to meet the unique needs of this high-risk population.

Building on our team's extensive experience in the fields of criminology and substance use, we propose to complete the development of a Continuing Care mobile application (app) and conduct a randomized controlled trial to assess efficacy among clients on probation or parole who are enrolled in outpatient substance use treatment. The app is designed to meet the recovery and personal support needs of probationers and parolees with SUDs who are at elevated risk of relapse, re-arrest, and incarceration. It is guided by the principles of the transtheoretical model of behavior change and app content is derived from the Your Own Reintegration System (YOURS) program, an empirically-supported16 intervention that focuses on substance use recovery, reducing criminal thinking and behavior, and managing and building support systems. If proven to be efficacious, the app could be deployed across the national network of outpatient treatment providers, and be highly significant in its direct impact on public health.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: The evaluation will involve a two-group RCT in which 100 men and women on probation or parole, who are currently receiving outpatient substance use treatment at THC, will be randomly assigned to one of two conditions: (1) Continuing Care app (CC app; n=50): Participants will receive the CC app, in addition to usual care at the treatment program (12-weeks of weekly group cognitive behavioral therapy), or (2) Treatment As Usual (TAU; n=50): Participants will only receive 12-weeks of weekly group cognitive behavioral therapy.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Continuing Care App for Probationers and Parolees With Substance Use Disorders
Estimated Study Start Date : February 8, 2021
Estimated Primary Completion Date : August 5, 2021
Estimated Study Completion Date : November 5, 2021

Arm Intervention/treatment
Experimental: Continuing Care App
Participants will receive the Continuing Care app, in addition to usual care at the treatment program (12-weeks of weekly group cognitive behavioral therapy).
Device: digital therapeutic for substance use disorders
The Continuing Care application (app) is a HIPAA-compliant, mobile-friendly, software program designed to meet the recovery and personal support needs of probationers and parolees with SUDs who are at elevated risk of relapse, re-arrest, and incarceration.

Active Comparator: Treatment As Usual
Participants will only receive 12-weeks of weekly group cognitive behavioral therapy.
Other: Treatment As Usual
12-weeks of weekly group cognitive behavioral therapy




Primary Outcome Measures :
  1. Weeks Retained in Substance Use Treatment [ Time Frame: up to 12 weeks ]
    Number of weeks retained in treatment based on a review of clinical records


Secondary Outcome Measures :
  1. Completion of Substance Use Treatment [ Time Frame: up to 12 weeks ]
    Treatment completed (yes or no) based on a review of clinical records

  2. Days of Substance Use [ Time Frame: up to 18 weeks ]
    Number of days of drug use based on self-report drug use and urine drug screen results

  3. Days of Criminal Activity; Re-arrest; Incarceration [ Time Frame: up to 18 weeks ]
    Number of crime days; re-arrest (yes or not); incarceration (yes or no) based on self-report information and public court record databases


Other Outcome Measures:
  1. Rating of App Satisfaction [ Time Frame: up to 12 weeks ]
    Rating of client satisfaction using the app based on self-report information



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 18 or older
  • Currently on community supervision (probation or parole) or justice-involvement in the past 12 months
  • Currently a client receiving outpatient substance use treatment
  • Willing to receive supplemental treatment services through a mobile app
  • Willing to provide informed consent and complete research assessments

Exclusion Criteria:

  • Severe psychiatric problems (e.g., untreated psychosis, untreated bipolar disorder)
  • Suicidality within the past 6-months, as determined by clinical staff, which could make participation in a novel treatment hazardous

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04574193


Contacts
Layout table for location contacts
Contact: Steven B Carswell, Ph.D. 410-837-3977 ext 252 scarswell@friendsresearch.org
Contact: Michael S Gordon, D.P.A. 410-837-3977 ext 251 mgordon@friendsresearch.org

Sponsors and Collaborators
COG Analytics
Friends Research Institute, Inc.
Investigators
Layout table for investigator information
Principal Investigator: Steven B Carswell, Ph.D. COG Analytics
Layout table for additonal information
Responsible Party: Steven Carswell, Principal Investigator, COG Analytics
ClinicalTrials.gov Identifier: NCT04574193    
Other Study ID Numbers: 2R44MD008848-02 ( U.S. NIH Grant/Contract )
First Posted: October 5, 2020    Key Record Dates
Last Update Posted: January 26, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: COG Analytics (COG) and Friends Research Institute (FRI) are committed to the open and timely dissemination of research outcomes. Investigators in the proposed study recognize that promising new methods, technologies, strategies and computer software may arise during the course of this research. The investigators are aware of, and agree to abide by, the principles for sharing research resources as described by the National Institutes of Health (NIH) in "Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Resources."

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders